{"title":"Visual outcomes, quality of vision, and patient satisfaction of a trifocal intraocular lens.","authors":"Marius A Scheepers, Nina M Pasin, Brad Hall","doi":"10.1016/j.jcjo.2025.01.018","DOIUrl":"10.1016/j.jcjo.2025.01.018","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate visual outcomes, patient satisfaction, and quality of vision after bilateral Clareon PanOptix implantation.</p><p><strong>Methods: </strong>This was a prospective, observational, single-arm, single-surgeon, single-site study of the clinical outcomes following implantation of the Clareon PanOptix (toric and nontoric). A total of 28 subjects (56 eyes) completed the study. At 3 months postoperatively, assessments included binocular uncorrected and distance-corrected visual acuity at distance (UDVA, CDVA), intermediate (UIVA, DCIVA; 60 cm), and near (UNVA, DCNVA; 40 cm), refraction, and patient-reported outcomes on a satisfaction questionnaire (IOLSAT) and a visual disturbance questionnaire (QUVID).</p><p><strong>Results: </strong>Mean postoperative binocular CDVA, DCIVA, and DCNVA were -0.02 ± 0.09, 0.03 ± 0.11, 0.04 ± 0.07 logMAR, respectively. In addition, mean binocular UDVA, UIVA, and UNVA were 0.00 ± 0.09, 0.06 ± 0.11, 0.03 ± 0.06 logMAR, respectively. Mean postoperative manifest refraction spherical equivalent (MRSE) was 0.01 ± 0.23 D and 96% of eyes had MRSE of 0.5 D or less. The percentage of subjects reporting spectacle independence at distance, intermediate, and near was 100%, 100%, and 89%, respectively. Moreover, 89% of subjects rated their satisfaction as \"Satisfied\" or \"Very Satisfied.\" Additionally, 0%, 8%, and 7% of subjects were \"bothered quite a bit\" or \"bothered very much\" by starbursts, halos, and glare, respectively.</p><p><strong>Conclusions: </strong>Patients in this study who were implanted with the Clareon PanOptix intraocular lens had excellent refractive and visual outcomes and reported good spectacle independence at distance, intermediate, and near, high overall satisfaction, and low visual disturbances.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143439874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"First reported autosomal recessive macular and cone dystrophy linked to homozygous PRPH2 variant in two Calabrian families.","authors":"Yi Zhai, Brian G Ballios","doi":"10.1016/j.jcjo.2025.02.003","DOIUrl":"10.1016/j.jcjo.2025.02.003","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143466940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lauren C Ditta, Asim F Choudhri, Andrew J Gienapp, Paul Klimo
{"title":"Optic nerve sheath fenestration for young patients with papilledema secondary to cerebral sinovenous thrombosis: a case series.","authors":"Lauren C Ditta, Asim F Choudhri, Andrew J Gienapp, Paul Klimo","doi":"10.1016/j.jcjo.2025.02.004","DOIUrl":"10.1016/j.jcjo.2025.02.004","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143499233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wiktor Stopyra, Oleksiy Voytsekhivskyy, Andrzej Grzybowski
{"title":"Accuracy of 7 artificial intelligence-based intraocular lens power calculation formulas in medium-long eyes: 2-center study.","authors":"Wiktor Stopyra, Oleksiy Voytsekhivskyy, Andrzej Grzybowski","doi":"10.1016/j.jcjo.2025.01.020","DOIUrl":"10.1016/j.jcjo.2025.01.020","url":null,"abstract":"<p><strong>Objective: </strong>To compare accuracy of 7 artificial intelligence (AI)-based intraocular lens (IOL) power calculation formulas in medium-long eyes DESIGN: Retrospective observational study.</p><p><strong>Methods: </strong>The data of patients with eyes with an axial length of 24.5 mm to 25.99 mm, who underwent phacoemulsification between May 2018 and September 2023 were analyzed. Inclusion criteria were complete biometric and refractive data. Exclusion criteria were intraoperative or postoperative complications, previous eye surgery, or corneal diseases, postoperative best-corrected visual acuity less than 0.8 and corneal astigmatism greater than 2.0 D. Prior to cataract surgery, IOL power was calculated using a Zeiss IOLMaster 700 (Carl Zeiss Meditec AG, Jena, Germany). The power of the implanted IOL was randomly selected from the outcomes of one of the following formulas, i.e., SRK/T, Holladay 2, or Barrett Universal II. Three months after phacoemulsification, refraction was measured. Postsurgery, IOL power calculations were performed using the following formulas: Hill-RBF 3.0, Kane, PEARL-DGS, Ladas Super Formula AI (LSF AI), Hoffer QST, Karmona, and Nallasamy. The main outcome measures used were SD, since prediction error (PE) was zeroed, and the percentage of eyes with PE was within ±0.50 D.</p><p><strong>Results: </strong>One hundred eighty-four eyes with axial lengths of between 24.50 mm and 25.97 mm, were studied. The Karmona formula obtained the lowest SD (0.322) just before Hill-RBF 3.0 (0.324) and Pearl-DGS (0.334), however, without statistical significance (p > 0.05). The highest percentage of eyes with PE within ±0.50 D was achieved by Karmona (89.67%) ahead of Hill-RBF 3.0, LSF AI and Pearl-DGS (all equally 87.50 each) without statistical significance (p > 0.490).</p><p><strong>Conclusions: </strong>All studied AI-based formulas provided highly accurate outcomes in medium-long eyes.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143447644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rahul Moorjani, Emi Sanders, Kyla Lavery, Ayman Abou Mehrem, Ravina Anand, Stephanie A Dotchin
{"title":"G-ROP versus WINROP for retinopathy of prematurity screening: a Calgary perspective.","authors":"Rahul Moorjani, Emi Sanders, Kyla Lavery, Ayman Abou Mehrem, Ravina Anand, Stephanie A Dotchin","doi":"10.1016/j.jcjo.2025.02.001","DOIUrl":"10.1016/j.jcjo.2025.02.001","url":null,"abstract":"<p><strong>Objective: </strong>Retinopathy of prematurity (ROP) remains one of the leading causes of childhood blindness. The current screening criteria in Canada have extremely high sensitivity but low specificity, leading to unnecessary examinations of neonates. Moreover, a screening algorithm that reduces the burden of screening is urgently needed owing to the increase in neonatal survival after extreme premature delivery, combined with the limited number of physicians qualified to screen for ROP. This retrospective study aimed to validate and compare the accuracy of the postnatal growth and ROP (G-ROP) and Weight, Insulin-like growth factor-1, Neonatal Retinopathy of Prematurity (WINROP) models for identifying neonates at risk for developing treatment-requiring ROP in a Canadian cohort.</p><p><strong>Design: </strong>Single-center retrospective cohort study conducted in Calgary, Alberta, Canada. Data from preterm infants born between 23- and 31-week gestational age or birth weight less than or equal to 1 250 grams were analyzed. A total of 1 001 infants were included in the study. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value for WINROP, and G-ROP algorithms were assessed in identifying neonates at risk of treatment-requiring ROP.</p><p><strong>Results: </strong>The WINROP algorithm yielded 95.7% sensitivity in identifying infants requiring ROP treatment compared to 100% sensitivity with the G-ROP model. Specificity for treatment-requiring ROP for WINROP was 41.7% and G-ROP was 30.4%.</p><p><strong>Conclusions: </strong>The G-ROP model was found to be more appropriate in our cohort, lending itself seamlessly to clinical care, while providing 100% sensitivity and greater specificity compared to current screening guidelines in our cohort.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143466946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kevin Hodgson, Mathew M Palakkamanil, Angela Zhang, Oksana M Dyachok, Corey A Smith, Marcelo T Nicolela, Balwantray C Chauhan, Lesya M Shuba
{"title":"Effect of ginkgo biloba extract on macula and peripapillary perfusion examined using optical coherence tomography angiography.","authors":"Kevin Hodgson, Mathew M Palakkamanil, Angela Zhang, Oksana M Dyachok, Corey A Smith, Marcelo T Nicolela, Balwantray C Chauhan, Lesya M Shuba","doi":"10.1016/j.jcjo.2025.01.015","DOIUrl":"10.1016/j.jcjo.2025.01.015","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effect of ginkgo biloba extract (GBE) on optical coherence tomography angiography (OCT-A) macula and peripapillary perfusion parameters among patients with treated early-to-moderate primary open-angle glaucoma.</p><p><strong>Design: </strong>Clinical trial.</p><p><strong>Participants: </strong>Seventeen patients with early-to-moderate (≥10 dB MD) primary open-angle glaucoma were matched to 17 control patients based on age, sex, and glaucoma status. A total sample size of 34 was determined for effect size 0.5, alpha 0.05, power 0.81, and critical t = 2.03. Normality was confirmed using the Kolmogorov-Smirnov and Shapiro-Wilk tests.</p><p><strong>Methods: </strong>The intervention was 120 mg oral GBE twice daily for 4 months. OCT-A scans (15° × 15°) of the macula and peripapillary retina were acquired, two-dimensional projection slab images of the superficial vascular complex were exported, and image analysis was performed. Student's t test was used to compare perfusion density between groups, and between baseline and follow-up for each group. The main outcomes were perfusion density of the superficial vascular complex of the macula and the peripapillary region.</p><p><strong>Results: </strong>Comparison between baseline and 4 months' supplementation with GBE revealed no significant change in perfusion density in the macular area, 0.32 (0.04) versus 0.30 (0.04); p = 0.17, and was significantly lower in the peripapillary area, 0.44 (0.05) versus 0.42 (0.04); p = 0.02. No differences were observed in the control group.</p><p><strong>Conclusion: </strong>Four-month supplementation with GBE did not result in clinically significant improvement in macula or peripapillary perfusion density in patients with treated early-to-moderate primary open-angle glaucoma. Larger studies are needed to confirm an absence of neuroprotective effects of GBE.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143439871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katherine Jara, Emma Youhnovska, Emily Marcotte, Lelia Marroquín, Jorge Villalobos, Yuliana Alvarez, Asami Kawaguchi, Erick Urbano, Jose Velasco-Stoll, Pedro Muro, Christian El-Hadad, Bryan Arthurs, Miguel N Burnier
{"title":"Clinicopathological comparison of benign eyelid tumours in tertiary care centers in Lima and Montreal from 2010 to 2019.","authors":"Katherine Jara, Emma Youhnovska, Emily Marcotte, Lelia Marroquín, Jorge Villalobos, Yuliana Alvarez, Asami Kawaguchi, Erick Urbano, Jose Velasco-Stoll, Pedro Muro, Christian El-Hadad, Bryan Arthurs, Miguel N Burnier","doi":"10.1016/j.jcjo.2025.01.008","DOIUrl":"10.1016/j.jcjo.2025.01.008","url":null,"abstract":"<p><strong>Objective: </strong>The eyelids are complex structures composed of various tissues. As such, a wide array of lesions exist that affect the eyelids. Clinical diagnosis of these lesions is essential to differentiate benign from malignant ones. Although accurate, some cases are misdiagnosed. Histopathology remains the crucial step in the final diagnosis of eyelid lesions. The objective of the study is to describe and compare the clinicopathological diagnosis of benign eyelid tumours between two tertiary care centers, one in South America and the other in North America, from 2010 to 2019.</p><p><strong>Methods: </strong>We reviewed 1 935 tumours at the McGill University Health Centre (MUHC)-McGill University Ocular Pathology and Translational Research Laboratory and 1 256 tumours collected at \"Dr. Jose Antonio Avendaño Valdez\" Ocular Pathology at the Instituto Nacional de Oftalmologia Peru (INO) (2010-2019). Demographic information and clinical and histopathological diagnoses were collected in an anonymized fashion.</p><p><strong>Results: </strong>The average age was 61.04 years at MUHC and 47.44 years at INO, benign tumours accounted for 78.11 % and 79.84%, respectively. The three most frequent benign tumour were squamous cell papilloma, nevus, and seborrheic keratosis at both sites. Lesions most commonly affected the upper and lower eyelid. 2.32% at the MUHC and 1.35% at the INO of cases were clinically misdiagnosed as benign tumours but confirmed malignant by histopathology.</p><p><strong>Conclusion: </strong>The most common lesions were squamous cell papilloma, nevus, and seborrheic keratosis, although the most common diagnosis varied, likely due to environmental factors differing at each site. Histopathology is essential for the accurate diagnosis of eyelid tumours.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicolás Kahuam-López, Jennifer Ym Ling, Alfonso Iovieno, Sonia N Yeung
{"title":"Accuracy of keratoconus-specific formulae compared to standard formulae for intraocular lens power calculation in patients with keratoconus.","authors":"Nicolás Kahuam-López, Jennifer Ym Ling, Alfonso Iovieno, Sonia N Yeung","doi":"10.1016/j.jcjo.2025.01.005","DOIUrl":"10.1016/j.jcjo.2025.01.005","url":null,"abstract":"<p><strong>Objective: </strong>To compare the accuracy of keratoconus-specific formulae for nontoric and toric intraocular lenses in eyes with keratoconus undergoing cataract surgery.</p><p><strong>Design: </strong>Consecutive retrospective case series.</p><p><strong>Participants: </strong>Patients with keratoconus who underwent cataract surgery.</p><p><strong>Methods: </strong>A retrospective chart review was conducted on cataract surgeries performed by the Cornea Service in the Department of Ophthalmology and Visual Sciences of the University of British Columbia from 2000 to 2023. The Kane keratoconus, Kane, Barrett Universal 2, Barrett True K, SRK II, SRK/T, Hoffer Q, Holladay I, EVO, Hill RBF and Hoffer QST, and Pearl DGS formulae were calculated. The postoperative mean absolute error (MAE) and mean prediction error (MPE) were calculated for each formula.</p><p><strong>Results: </strong>A total of 133 eyes from 88 patients were eligible for inclusion in the study, 113 from 74 patients received nontoric IOLs, and 20 from 14 patients received toric IOLs. Pearl DGS had the most myopic MPE of -0.51 ± 1.04, which was statistically significant (p < 0.001) compared to all other formulae. There were no statistically significant differences in the MPE and MAE of the Kane keratoconus, Kane, Barrett Universal 2, Barrett True K keratoconus-specific formula, SRK II, SRK/T, Hoffer Q, Holladay I, EVO, Hill RBF and Hoffer QST formulae (p > 0.05).</p><p><strong>Conclusion: </strong>There was no difference in IOL power estimation accuracy with keratoconus-specific formulae compared to conventional formulae for cataract surgery in KC patients. The IOL power estimation in KC remains significantly less accurate compared with non-KC patients.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of implementation of an electronic consult referral platform (eConsult) to triage retina referrals in Manitoba.","authors":"Ekaterina Milovanova, Teresa Park, Frank Stockl","doi":"10.1016/j.jcjo.2025.01.014","DOIUrl":"10.1016/j.jcjo.2025.01.014","url":null,"abstract":"<p><strong>Objective: </strong>eConsult allows specialists to diagnose and recommend treatment plans for nonurgent conditions without the need for patient travel. Our purpose is to evaluate the effectiveness of eConsult in reducing unnecessary in-person retinal consultations in Manitoba.</p><p><strong>Design: </strong>Retrospective eConsult chart review.</p><p><strong>Participants: </strong>Any person for whom an eConsult was submitted for a retina problem in Manitoba between November 2020 and October 2023 (n = 196).</p><p><strong>Methods: </strong>The primary objective was to quantify eConsults requiring no in-person referral, routine in-person referral, or urgent (within 4 weeks) in-person referral. Secondary objectives included describing characteristics of eConsults and quantifying the amount of time spent on the platform by both the referring provider and the specialist. On the basis of these variables, patient travel, consultation time, and specialist billings savings were calculated.</p><p><strong>Results: </strong>66.8% of eConsults did not require in-person assessment (n = 131), 24.5% required to be seen on a routine basis (n = 48), and 8.7% required to be seen within 4 weeks (n = 17). This translated to a net cost of $2,660.43 for the provincial government in billings over 3 years, but 81 990 km saved in patient travel. 99% of eConsults came from optometrists (n = 194). Referring providers spent an average of 10.6 ± 9.4 minutes on the platform per referral, and the specialist consultant spent 9.1 ± 6.6 minutes.</p><p><strong>Conclusion: </strong>eConsult is a potentially cost-effective way to address increasing demand for retinal services, reduce wait times by reducing unnecessary referrals, and facilitate data sharing between optometrists and ophthalmologists.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143188401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Khaldon Abbas, Rem Aziz, Najwa Jawhar, Shakeel Qazi, Bader AlQahtani, Saama Sabeti, Kashif Baig
{"title":"Visual outcomes and safety profile of retropupillary iris-claw Artisan intraocular lens implants.","authors":"Khaldon Abbas, Rem Aziz, Najwa Jawhar, Shakeel Qazi, Bader AlQahtani, Saama Sabeti, Kashif Baig","doi":"10.1016/j.jcjo.2025.01.013","DOIUrl":"10.1016/j.jcjo.2025.01.013","url":null,"abstract":"<p><strong>Objective: </strong>The Artisan is an iris-claw intraocular lens (IOL) that can be used to correct aphakia in eyes with insufficient capsular support. This study aims to evaluate long-term visual outcomes and complications following retropupillary implantation of the Artisan IOL at a Canadian centre.</p><p><strong>Design: </strong>Retrospective chart review.</p><p><strong>Participants: </strong>Patients who underwent implantation of an Artisan IOL at a tertiary Canadian center between January 2013 and December 2021.</p><p><strong>Methods: </strong>Retrospective chart review was performed, and clinical outcomes at postoperative follow-up visits were summarized. Outcomes included postoperative best corrected and uncorrected distance visual acuity (BCDVA and UCDVA), intraocular pressure (IOP), as well as intraoperative and postoperative complications.</p><p><strong>Results: </strong>Seventy-three eyes of 67 patients were evaluated. Mean follow-up duration was 11 months (range: 1-63 months). Common indications for Artisan implantation were IOL dislocation (n = 50; 68.5%) and aphakia (n = 23; 31.5%). Causes for IOL dislocation included idiopathic zonular weakness (n = 25; 34.2%), pseudo-exfoliation (n = 14; 19.2%), surgical complications (n = 6; 8.2%), trauma (n = 3; 4.1%), and Marfan syndrome (n = 2; 2.7%). Causes for aphakia included complicated cataract surgery (n = 20; 27.4%), ocular trauma (n = 2; 2.7%), and post-vitrectomy and lensectomy (n = 1; 1.4%). Average BCDVA (logMAR) was 0.62 ± 0.56 at preop, 0.46 ± 0.55 at 3 months postop, and 0.43 ± 0.55 at 9-12 months (p < 0.0001). Average UCDVA (logMAR) was 1.19 ± 0.68 at preop, 0.65 ± 0.60 at 3 months postop, and 0.42 ± 0.46 at 9-12 months (p < 0.0001). IOP did not differ significantly in follow-up. Pupil ovalization (n = 11, 15.1%) was the most common complication.</p><p><strong>Conclusions: </strong>Outcomes demonstrated favourable efficacy and safety of retropupillary Artisan IOL as an option for providing adequate visual rehabilitation for patients without sufficient capsular support.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143373868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}